Endothelial dysfunction and cardiorenal injury in experimental salt- sensitive hypertension: Effects of antihypertensive therapy

Circulation

Volumn 96, Issue 7, 1997, Pages 2407-2413

  Hayakawa, Hiroshi ^a   Coffee, Karen ^a   Raij, Leopoldo ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

Cardiovascular diseases; Endothelium; Hypertension; Kidney; Nitric oxide

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDAPAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY COMPLIANCE; ARTICLE; BLOOD VESSEL COMPLIANCE; BLOOD VESSEL TONE; CARDIOVASCULAR RESPONSE; CELL FUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HEART INJURY; HOMEOSTASIS; HYPERTENSION; KIDNEY INJURY; NONHUMAN; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

EID: 0030798337     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.7.2407     Document Type: Article

References (39)

1. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease, I: prolonged differences in blood pressure - prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
2. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease, II: short-term reductions in blood pressure - overview of randomized drug trials in their epidemiological context. Lancet. 1990;335:827-838.
3. Rostand SG, Brown G, Kirk KA, Rutsky EA, Dustan HP. Renal insufficiency in treated essential hypertension. N Engl J Med. 1989; 320:684-688.
4. Jaimes E, Galceran J-M, Raij L. End-organ renal disease: why aren't improvements in hypertensive treatment reducing the risk? Curr Opin Cardiol. 1996;11:471-476.
5. Castelli WP, Wilson PW, Levy D, Anderson K. Cardiovascular risk factors in the elderly. Am J Cardiol. 1989;63:12H-19H.
6. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med. 1989;110:101-107.
7. Tolins JP, Shultz P, Raij L. Mechanisms of hypertensive glomerular injury. Am J Cardiol. 1988;62:54G-58G.
8. Campese VM, Tawadrous M, Bigazzi R, Bianchi S, Mann AS, Oparil S, Raij L. Salt intake and plasma atrial natriuretic peptide and nitric oxide in hypertension. Hypertension. 1996;28:335-340.
9. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Dietary salt intake: a determinant of cardiac involvement in essential hypertension. Circulation. 1988;78:951-956.
10. Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM. Microalbuminuria in salt-sensitive patients: a marker for renal and cardiovascular risk factors. Hypertension. 1994;23:195-199.
11. Hayakawa H, Hirata Y, Suzuki E, Sugimoto T, Matsuoka H, Kikuchi K, Nagano T, Hirobe M, Sugimoto T. Mechanisms for altered endothelium-dependent vasorelaxation in isolated kidneys from experimental hypertensive rats. Am J Physiol. 1993;264: H1535-H1541.
12. Luscher TF, Raij L, Vanhoutte PM. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension. 1987;9:157-163.
13. Raij L, Luscher TF, Vanhoutte PM. High potassium diet augments endothelium-dependent relaxations in the Dahl rat. Hypertension. 1988;12:562-567.
14. Hayakawa H, Raij L. The link among nitric oxide synthase activity, endothelial function and aortic and ventricular hypertrophy in hypertension. Hypertension. 1997;29(pt 2):235-241.
15. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984; 26:137-143.
16. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
17. Hirata Y, Hayakawa H, Suzuki E, Omata M. Does endothelin work as an intrarenal mechanism to alter pressure natriuresis in spontaneously hypertensive rats? J Hypertens. 1994;12:251-257.
18. Raij L, Nagy J, Coffee K, DeMaster EG. Hypercholesterolemia promotes endothelial dysfunction in vitamin E- and selenium-deficient rats. Hypertension. 1993;22:56-61.
19. McGregor D. Effect of sympathetic nerve stimulation on the vasoconstrictor responses in perfused mesenteric blood vessels of the rat. J Physiol. 1965;177:21-30.
20. Salter M, Knowles RG, Moncada S. Widespread tissue distribution, species distribution and changes in activity of Ca(2+)-dependent and Ca(2+)-independent nitric oxide synthases. FEBS Lett. 1991; 291:145-149.
21. Singer DR, Markandu ND, Cappuccio FP, Miller MA, Sagnella GA, MacGregor GA. Reduction of salt intake during converting enzyme inhibitor treatment compared with addition of a thiazide. Hypertension. 1995;25:1042-1044.
22. Weinberger MH. Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients. J Cardiovasc Pharmacol. 1985;7:S52-S55.
23. Peeler TC, Baker KM, Esmurdoc CF, Chemin MI. Angiotensin converting enzyme inhibition in Dahl salt-sensitive rats. Mol Cell Biol. 1991;104:45-50.
24. Uehara Y, Shirahase H, Nagata T, Ishimitsu T, Morishita S, Osumi S, Matsuoka H, Sugimoto T. Radical scavengers of indapamide in prostacyclin synthesis in rat smooth muscle cell. Hypertension. 1990; 15:216-224.
25. Junquero DC, Schini VB, Vanhoutte PM. Indapamide potentiates the endothelium-dependent production of cyclic guanosine monophosphate by bradykinin in the canine femoral artery. Am Heart J. 1991;122:1204-1209.
26. Boulanger CM, Mombouli JV, Vanhoutte PM. Indapamide inhibits endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Fundam Clin Pharmacol. 1993;7:443-448.
27. Lariviere R, Thibault G, Schiffrin EL. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension. 1993;21:294-300.
28. Dohi Y, Luscher TF. Endothelin in hypertensive resistance arteries: intraluminal and extraluminal dysfunction. Hypertension. 1991;18: 543-549.
29. Deng LY, Schiffrin EL. Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats. Am J Physiol. 1992;262:H1782-H1787.
30. Li JS, Lariviere R, Schiffrin EL. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats: evidence for a role of endothelin in vascular hypertrophy. Hypertension. 1994;24:183-188.
31. Ryan US, Zhong R, Hayes BA, Visner G, Sauther ML. Regulation of endothelin-1 expression in normal and transfected endothelial cells. J Cardiovasc Pharmacol. 1993;22:S38-S41.
32. Stefas L, Levy BI. Effects of saralasin on arterial compliance in normotensive and hypertensive rats: role of endothelium. Hypertension. 1991;18:II-30-II-36.
33. Benetos A, Bouaziz H, Albaladejo P, Guez D, Safar ME. Carotid artery mechanical properties of Dahl salt-sensitive rats. Hypertension. 1995;25:272-277.
34. Boutouyrie P, Laurent S, Girerd X, Benetos A, Lacolley P, Abergel E, Safar M. Common carotid artery stiffness and patterns of left ventricular hypertrophy in hypertensive patients. Hypertension. 1995;25:651-659.
35. Frohlich ED. Overview of hemodynamic and non-hemodynamic factors associated with left ventricular hypertrophy. J Mol Cell Cardiol. 1989;21:3-10.
36. Frohlich ED, Tarazi RC. Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol. 1979;44:959-963.
37. Ting CT, Brin KP, Lin SJ, Wang SP, Chang MS, Chiang BN, Yin FC. Arterial hemodynamics in human hypertension. J Clin Invest. 1986;78:1462-1471.
38. Clozel M, Kuhn H, Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension. 1990;16:532-540.
39. Shultz PJ, Raij L. Effects of antihypertensive agents on endothelium-dependent and endothelium-independent relaxations. Br J Clin Pharmacol. 1989;28:151S-157S.